LION POINT CAPITAL, LP
1 follower · Follow
Lion Point Capital is based out of New York. Lion Point Capital is a hedge fund with 7 clients and discretionary assets under management (AUM) of $410,264,663 (Form ADV from 2025-03-31). Their last reported 13F filing for Q3 2025 included $17,601,836 in managed 13F securities
and a top 10 holdings concentration of 58.11%. Lion Point Capital's largest holding is Mineralys Therapeutics Inc with shares held of 39,000. Whalewisdom has at least 41 13F filings, 19 13D filings, 18 13G filings, and 4 Form 4 filings
Business Description
There is not enough information to summarize the advisory business. Item 4 refers to advisory business, but the content of Item 4 is not included in the context.
Investment Strategy
The Funds aim for attractive long-term, absolute returns across market cycles while preserving capital through security selection, in-depth analysis, and rigorous risk management. They generally invest in all manner of securities, financial instruments, and obligations, including equity and debt securities, bank debt, trade debt, sovereign debt, contractual and litigation claims, market and sector indices, and derivatives. An exception is the Life Sciences Fund, which predominantly invests in equity and debt securities, as well as in sector indices and derivatives.
The firm's investment philosophy is event-driven and activist, spanning the entire capital structure. They trade or invest in a wide variety of financial instruments, including stocks, bonds, bank loans, swaps, credit default swaps, options, futures, forwards, swaptions, private equity, and correlation products. Their trading mandates are extremely broad, encompassing virtually every type of asset, investment interest, security, or property that can be traded or purchased.
Known Email Addresses
(Subscription Required)
Other Contact Information
(Subscription Required)